Vessel occlusion was achieved in 78 patients after MVP release, while in 26 subjects additional embolics were required; therefore the overall technical success was 75%. Primary clinical success was 96.1%.
Concerning anticoagulation therapy at the time of the procedure, no statistical differences (p-value = 0.6) were observed in terms of technical success between patients assuming and not assuming.
A straight landing zone was statistically associated with higher technical success compared to a curved one (p-value < 0.001); similarly, a landing zone longer than the unsheated MVP length was associated with higher technical success compared to a shorter one (p-value = 0.048).
MVP-3 group analysis
34 MVP-3 have been adopted in 31 patients (Table 2). The target arteries were: segmental hepatic (2), bronchial (2), intercostal-lumbar (2), inferior epigastric (3), division branch of the renal (4) (Fig. 2), hypogastric branches (4), gastrointestinal (4) and limbs vessels (13).
The target vessel caliper was in mean 2.1mm (range: 0.6–2.8).
13/34 MVP (38.2%) were released after other embolic failed to obtain vessel occlusion.
Technical success was obtained in 23/34 patients (67.6%); in 11 cases, other embolics were required to achieve the vessel embolization (coils in 6 patients, spongel slurry in 4 cases and glue in 1 case).
Primary clinical success was obtained in 28 patients (90.3%), secondary clinical success in 2 (6.5%); one patient had clinical failure with death for hypovolemic shock (3.2%).
The ROC curve analysis showed a slight trend to technical success in case the MVP was deployed in a vessel with a caliper < 2.1mm (AUC: 0.326).
MVP-5 group analysis
57 MVP-5 have been adopted in 51 patients (Table 2). The target arteries were: splenic (1), pulmonary branches (2), gastrointestinal (2), bronchial (2), segmental hepatic (3), external carotid branches (4) (Fig. 3), intercostal-lumbar (7), inferior epigastric (8), hypogastric branches (8), division branch of the renal (9) and limbs vessels (11).
The target vessel caliper was in mean 3.2mm (range: 1.1–5).
31/57 MVP (54.4%) were released after other embolic failed to obtain vessel occlusion.
Technical success was obtained in 35/57 patients (61.4%); in 22 cases, other embolics were required to achieve the vessel embolization (coils in 12 patients, spongel slurry in 7 cases and glue in 3 cases).
Primary clinical success was obtained in 50 patients (98%), secondary clinical success in the other one (2%).
The ROC curve analysis showed a slight trend to technical success in case the MVP was deployed in a vessel with a caliper < 3.1mm (AUC: 0.405).
MVP-7 group analysis
12 MVP-7 have been adopted in 11 patients (Table 2). The target arteries were: splenic (1), limbs vessel (1), gastroduodenal (2) (Fig. 4), inferior epigastric artery (3) and renal trunk (5).
The target vessel caliper was in mean 4.5mm (range: 2.7–5.1).
6/12 MVP (50%) were released after other embolic failed to obtain vessel occlusion.
Technical success was obtained in 11/12 patients (91.7%); in 1 case other embolics were required to achieve the vessel embolization (coils).
Primary clinical success was obtained in all patients (100%).
MVP-9 group analysis
13 MVP-9 have been adopted in 11 patients (Table 2). The target arteries were: hepatic (1), external carotid (1), gastroduodenal (1), limbs vessel (2), pulmonary branches (2) and splenic (6).
The target vessel caliper was in mean 6.5mm (range: 2.7–8).
1/13 MVP (7.7%) was released after other embolics failed to obtain vessel occlusion.
Technical success was obtained in 9/13 patients (69.2%); in 4 cases other embolics were required to achieve the vessel embolization (coils in 3 patients and glue in one patients).
Primary clinical success was obtained in all patients (100%).
According to CIRSE classification system for complications (Filippiadis et al. 2017), no clinically adverse events directly related to MVP device occurred. Three MVP migrated distally after release; in one patient the landing zone was shorter than the unsheated MVP (Fig. 5), while in the other two the landing zone was curved in a splenic artery.